Vireo Growth Inc. (CSE: VREO)
VREO trades on the Canadian Securities Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for VREO.CN, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | VREO on the Canadian Securities Exchange |
| Yahoo symbol | VREO.CN |
| Sector | Life Sciences, Drug Manufacturers—Specialty & Generic |
| Headquarters | British Columbia |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 57,117,981 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001771706 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | -8.9% |
| 1 week | -4.5% |
| 1 month | -30.7% |
| 3 months | -41.4% |
| 6 months | -47.7% |
| Year to date | -64.7% |
| 1 year | -60.9% |
| From 52-week high | -67.4% |
| 52-week range | C$8.79 to C$27.00 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
332 documents in 11 types. Each title links to the document at its source.
Annual financial statements (2)
| Document | Type | Filed |
|---|---|---|
| Audited carve-out combined financial statements of The Hawthorne Business of The Scotts Miracle-Gro Company as of September 30, 2025, and for the… Period 2025-09-30 | Annual financial statements (8-K/A) | 2026-06-18 |
| Audited consolidated financial statements of Eaze, Inc. and its subsidiaries as of December 31, 2025. | Annual financial statements (8-K/A) | 2026-06-11 |
Interim financial statements (7)
| Document | Type | Filed |
|---|---|---|
| Unaudited carve-out condensed combined financial statements of The Hawthorne Business of The Scotts Miracle-Gro Company as of December 27, 2025 and… | Interim financial statements (8-K/A) | 2026-06-18 |
| Unaudited pro forma condensed combined financial statements of Vireo Growth, Inc., Eaze, Inc., and The Hawthorne Gardening Company, LLC as of and for… Period 2025-12-31 | Interim financial statements (8-K/A) | 2026-06-18 |
| Unaudited pro forma condensed combined financial statements of Vireo Growth Inc. and Eaze Inc. as of December 31, 2025. | Interim financial statements (8-K/A) | 2026-06-11 |
| Unaudited financial statements of Proper Holdings, LLC as of and for the three months ended March 31, 2025 and 2024. Period 2025-03-31 | Interim financial statements (8-K/A) | 2025-08-08 |
News release (42)
| Document | Type | Filed |
|---|---|---|
| Press Release, dated as of November 10, 2026** | News release (8-K) | 2026-11-10 |
| Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility Transaction supports ownership of key cultivation and production… | News release (8-K) | 2026-10-08 |
| Vireo Growth Inc. Completes Acquisition of C21 Investments Inc. | News release (8-K) | 2026-08-26 |
| Vireo Growth Inc. Announces Share Buyback Program | News release (8-K) | 2026-08-18 |
Management information circular / proxy (6)
| Document | Type | Filed |
|---|---|---|
| DEF 14A | Proxy statement (DEF 14A) | 2026-04-16 |
| DEFA14A | Proxy statement (DEFA14A) | 2026-04-16 |
| PRE 14A | Proxy statement (PRE 14A) | 2026-04-06 |
| DEF 14A | Proxy statement (DEF 14A) | 2025-05-09 |
Prospectus (6)
| Document | Type | Filed |
|---|---|---|
| S-4/A | Registration statement (S-4/A) | 2026-10-30 |
| S-4 | Registration statement (S-4) | 2026-10-09 |
| FORM S-3 | Registration statement (S-3) | 2026-04-23 |
| FORM S-3 | Registration statement (S-3) | 2025-12-09 |
Annual report (2)
| Document | Type | Filed |
|---|---|---|
| 10-K Period 2025-12-31 | Annual report (10-K) (10-K) | 2026-03-17 |
| 10-K Period 2024-12-31 | Annual report (10-K) (10-K) | 2025-03-04 |
Quarterly report (7)
| Document | Type | Filed |
|---|---|---|
| 10-Q Period 2026-09-30 | Quarterly report (10-Q) (10-Q) | 2026-11-12 |
| 10-Q Period 2026-06-30 | Quarterly report (10-Q) (10-Q) | 2026-08-14 |
| 10-Q Period 2026-03-31 | Quarterly report (10-Q) (10-Q) | 2026-05-12 |
| 10-Q Period 2025-09-30 | Quarterly report (10-Q) (10-Q) | 2025-11-12 |
Early warning / ownership (9)
| Document | Type | Filed |
|---|---|---|
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2026-11-10 |
| Schedule 13D | Schedule 13D (SCHEDULE 13D) | 2025-08-01 |
| Schedule 13D | Schedule 13D (SCHEDULE 13D) | 2025-05-23 |
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2025-04-22 |
Insider report (55)
| Document | Type | Filed |
|---|---|---|
| Form 3 | Form 3 (3) | 2026-11-13 |
| Form 3 | Form 3 (3) | 2026-11-13 |
| Form 3 | Form 3 (3) | 2026-06-08 |
| Form 3 | Form 3 (3) | 2026-04-07 |
Certification (27)
| Document | Type | Filed |
|---|---|---|
| EX-31.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
| EX-31.2 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
| EX-32.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
| EX-32.1 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-08-14 |
Other (169)
| Document | Type | Filed |
|---|---|---|
| 8-K | Current report (8-K) (8-K) | 2026-11-10 |
| FORM 8-K | Current report (8-K) (8-K) | 2026-10-08 |
| FORM 8-K | Current report (8-K) (8-K) | 2026-08-26 |
| FORM 8-K | Current report (8-K) (8-K) | 2026-08-18 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
Trading: the last notice, on 2026-06-05, was a resumption.
| Notice | Action | Reason | Notice |
|---|---|---|---|
| 2026-06-05 9:30 AM ET | Resumption | No reason stated | CIRO notice |
| 2026-06-05 8:36 AM ET | Halt | Due to Imbalance of Orders | CIRO notice |
| 2025-09-04 10:00 AM ET | Resumption | No reason stated | CIRO notice |
| 2025-09-03 3:38 PM ET | Halt | Pending Company Contact | CIRO notice |
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Recent
| Date | Time | Event | Webcast | Source |
|---|---|---|---|---|
| 2026-11-10 | No time in the announcement | Q3 earnings release | No webcast link announced | SEC filing |
| 2026-11-10 | 8:00 a.m. ET | Q3 earnings call | Webcast | SEC filing |
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2026-10-07 | Equity | US$7.5M | US$7.5M | SEC EDGAR |
| 2026-10-02 | Equity | US$210K | US$210K | SEC EDGAR |
| 2026-08-24 | Equity, Option To Acquire, Other | US$47.7M | US$48.7M | SEC EDGAR |
| 2026-06-29 | Equity, Debt, Other | US$1.1M | US$1.1M | SEC EDGAR |
| 2026-06-22 | Debt, Option To Acquire, Security To Be Acquired, Other | US$13.7M | US$13.7M | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| SNDL | SNDL Inc. | CSE | C$510.9M | +16.2% | -18.5% |
| FRX | Fennec Pharmaceuticals Inc. | TSX | C$522.2M | +14.3% | +50.8% |
| EPRX | Eupraxia Pharmaceuticals Inc. | TSX | C$640.1M | +21.5% | +32.7% |
| WEED | Canopy Growth Corporation | TSX | C$393.7M | -25.0% | -47.1% |
| ACB | Aurora Cannabis Inc. | TSX | C$372.0M | +15.4% | +14.4% |
The app has the price chart, every filing, private raises and the full peer set for VREO.
Open in the app